Abstract
Diabetic kidney disease commonly is associated with an increased risk of cardiovascular disease. There are traditional common risk factors for both conditions including hypertension and poor glycemic control. However, it is likely that there are other pathophysiological mechanisms that explain the clinical phenomenon of increased cardiovascular disease in diabetic patients with chronic kidney and vice versa. Current management of both conditions includes aggressive glucose and blood pressure control. The protective role of treating dyslipidemia has been shown for cardiovascular disease, but the results for renal disease are not as clear. The advent of new classes of glucose-lowering agents such as sodium glucose co-transporter2 inhibitors and glucagon-like peptide-1 agonists has resulted in impressive effects on both cardiovascular and renal disease in diabetes. However, how these drugs act independently of glucose lowering to confer both kidney and cardiovascular protection has not been fully elucidated. Nevertheless, these new treatments provide optimism for reducing both microvascular and macrovascular complications in diabetes, which represent the major causes of morbidity and premature mortality in this condition.
Citations
Nov 12, 2019·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Friedrich C PrischlChristoph Wanner
Oct 8, 2019·Cardiovascular Endocrinology & Metabolism·Andrew J Krentz, Stephan Jacob
Aug 4, 2020·Diabetes, Obesity & Metabolism·Christoph WannerUNKNOWN EMPA-REG OUTCOME Investigators
Jul 28, 2019·Diabetologia·Stephanie EidPatrice E Fort
Aug 15, 2019·Journal of Translational Medicine·Gang WangLu Xie
Oct 3, 2020·Journal of Cardiothoracic Surgery·Rui WangXin Chen
Sep 15, 2020·Lipids in Health and Disease·Monique F M SantanaMarisa Passarelli
Aug 11, 2020·Oxidative Medicine and Cellular Longevity·Jing GuoWei Jing Liu
Oct 1, 2019·American Journal of Physiology. Renal Physiology·Oleg PalyginAlexander Staruschenko
Jan 10, 2021·Journal of Diabetes and Its Complications·Naresh KanumilliJohannes Nolte
Mar 3, 2020·Diabetes Research and Clinical Practice·María Dolores García de LucasJulián Olalla Sierra
Nov 19, 2020·Antioxidants·Abraham Said Arellano-BuendíaHoracio Osorio-Alonso
May 22, 2021·Acta Diabetologica·Qiong WangBin Gao
Jun 3, 2021·Biomolecules·Liang-Jun Yan
May 25, 2021·The American Journal of Medicine·Neha J Pagidipati, Prakash Deedwania
Jun 15, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·TingTing ZhaoPing Li
Oct 9, 2021·Medicine·Yusuke ShibataMitsuhisa Komatsu
Aug 4, 2021·Endocrinology·Moein Ala
May 26, 2021·Journal of Diabetes Investigation·Kazuhisa TakahashiSoroku Yagihashi
Dec 16, 2021·Journal of Cellular Biochemistry·Jing ChenYong-Yu Yang